NanoViricides, based in Shelton, Connecticut, outlined its approach to developing therapies against COVID-19 at the LD 500 investor conference yesterday. Anil R. Diwan, company president and executive chairman, indicated that since January 2020, they have been working with very limited…
Vir Bio and GSK Join the Race for a COVID-19 Monoclonal Antibody Therapy
Vir Biotechnology and GlaxoSmithKline dosed the first patient last week in a Phase II/III clinical trial of VIR-7831, a fully human monoclonal antibody against COVID-19. The trial is evaluating the therapy as early treatment for COVID-19 patients at high risk…
IL-6 Inhibitor Kevzara Flops in Second Phase III COVID-19 Study
Another Kevzara study in hospitalized COVID-19 patients failed to meet primary and secondary endpoints. This marks the second such failed study for Kevzara and at least the third with IL-6 inhibitors as a potential treatment for these patients. This morning,…
How collaboration and secure data transfer is transforming clinical trials
The modern life sciences environment is increasingly focused around cloud-based work and collaboration. This requires secure, reliable and GxP-compliant data transfer software, such as that offered by Egnyte. Therapeutics, medical devices and diagnostics require effective collaboration to successfully progress from…
Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of all ongoing and planned hepatology trials globally. Liver diseases are highly prevalent in the Asia-Pacific region. The region hosts some…
Mankind Pharma ties up with South Korean co for clinical trials of Covid-19 drug
The trial is designed towards addressing the need for an investigation on this new formulation based on encouraging preclinical evidence for the treatment of Covid-19, Mankind Pharma said in a statement. Mankind Pharma on Tuesday said it has collaborated with…
Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling
Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthy adults at clinical trial sites in the United States. Many of the trial sites and study…
Celularity begins trial of COVID-19 cell therapy
Celularity has received funding to support a phase I/II clinical trial of human placental hematopoietic stem cell-derived natural killer cells (CYNK-001) for the treatment of COVID-19. The company was awarded $750,000 by the California Institute for Regenerative Medicine. The funds…
Romark begins Phase III trial of Covid-19 drug candidate
Biopharmaceutical company Romark has commenced a Phase III trial of its new investigational drug candidate NT-300 (nitazoxanide) for the treatment of mild or moderate Covid-19. The multicentre, randomised, double-blind trial of the NT-300 drug containing nitazoxanide extended-release tablets will involve…
UK places order for 60m doses of Sanofi/GSK’s COVID-19 vaccine
The UK government has signed its fourth coronavirus vaccine deal, snapping up 60 million doses of an experimental shot being developed by Sanofi and GlaxoSmithKline. The order has come in even before the vaccine has started clinical development, with a…
